Janus Henderson Group’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $346M | Buy |
2,676,012
+99,256
| +4% | +$14.3M | 0.17% | 138 |
|
|
2025
Q4 | $368M | Buy |
2,576,756
+103,220
| +4% | +$13.8M | 0.16% | 133 |
|
|
2025
Q3 | $297M | Buy |
2,473,536
+3,390
| +0.1% | +$430K | 0.14% | 146 |
|
|
2025
Q2 | $326M | Buy |
2,470,146
+20,789
| +0.8% | +$2.82M | 0.16% | 136 |
|
|
2025
Q1 | $343M | Buy |
2,449,357
+38,575
| +2% | +$5.99M | 0.19% | 128 |
|
|
2024
Q4 | $374M | Sell |
2,410,782
-856
| -0% | -$145K | 0.19% | 121 |
|
|
2024
Q3 | $439M | Sell |
2,411,638
-31,967
| -1% | -$4.73M | 0.22% | 106 |
|
|
2024
Q2 | $290M | Sell |
2,443,605
-27,891
| -1% | -$2.93M | 0.16% | 136 |
|
|
2024
Q1 | $265M | Sell |
2,471,496
-146,437
| -6% | -$14.6M | 0.14% | 150 |
|
|
2023
Q4 | $261M | Buy |
2,617,933
+93,157
| +4% | +$9.11M | 0.16% | 149 |
|
|
2023
Q3 | $300M | Sell |
2,524,776
-31,571
| -1% | -$4.71M | 0.2% | 126 |
|
|
2023
Q2 | $456M | Sell |
2,556,347
-4,522
| -0.2% | -$830K | 0.28% | 92 |
|
|
2023
Q1 | $422M | Buy |
2,560,869
+3,643
| +0.1% | +$627K | 0.28% | 93 |
|
|
2022
Q4 | $403M | Sell |
2,557,226
-2,457,692
| -49% | -$374M | 0.29% | 89 |
|
|
2022
Q3 | $755M | Buy |
5,014,918
+2,466,590
| +97% | +$410M | 0.28% | 89 |
|
|
2022
Q2 | $419M | Buy |
2,548,328
+72,209
| +3% | +$13.9M | 0.29% | 89 |
|
|
2022
Q1 | $551M | Buy |
2,476,119
+181,239
| +8% | +$40.6M | 0.27% | 88 |
|
|
2021
Q4 | $545M | Sell |
2,294,880
-6,141
| -0.3% | -$1.43M | 0.23% | 106 |
|
|
2021
Q3 | $537M | Sell |
2,301,021
-34,095
| -1% | -$7.15M | 0.23% | 102 |
|
|
2021
Q2 | $481M | Sell |
2,335,116
-90,766
| -4% | -$18.7M | 0.21% | 117 |
|
|
2021
Q1 | $498M | Sell |
2,425,882
-197,812
| -8% | -$41.8M | 0.23% | 108 |
|
|
2020
Q4 | $563M | Sell |
2,623,694
-323,569
| -11% | -$62.8M | 0.26% | 89 |
|
|
2020
Q3 | $539M | Buy |
2,947,263
+308,854
| +12% | +$58.1M | 0.28% | 77 |
|
|
2020
Q2 | $486M | Sell |
2,638,409
-130,356
| -5% | -$25.9M | 0.27% | 83 |
|
|
2020
Q1 | $559M | Sell |
2,768,765
-99,506
| -3% | -$19.2M | 0.38% | 55 |
|
|
2019
Q4 | $537M | Buy |
2,868,271
+30
| +0% | +$5.16K | 0.27% | 88 |
|
|
2019
Q3 | $458M | Buy |
2,868,241
+42,405
| +2% | +$8.44M | 0.25% | 95 |
|
|
2019
Q2 | $712M | Buy |
2,825,836
+140,123
| +5% | +$32.5M | 0.39% | 59 |
|
|
2019
Q1 | $643M | Buy |
2,685,713
+31,946
| +1% | +$7.66M | 0.36% | 61 |
|
|
2018
Q4 | $609M | Buy |
2,653,767
+1,282,922
| +94% | +$316M | 0.39% | 54 |
|
|
2018
Q3 | $388M | Buy |
1,370,845
+7,475
| +0.5% | +$2.19M | 0.21% | 125 |
|
|
2018
Q2 | $400M | Sell |
1,363,370
-12,411
| -0.9% | -$3.39M | 0.23% | 118 |
|
|
2018
Q1 | $347M | Sell |
1,375,781
-120,651
| -8% | -$28.4M | 0.2% | 137 |
|
|
2017
Q4 | $323M | Sell |
1,496,432
-187,662
| -11% | -$38M | 0.2% | 146 |
|
|
2017
Q3 | $313M | Buy |
1,684,094
+251,793
| +18% | +$43.9M | 0.2% | 149 |
|
|
2017
Q2 | $247M | Buy |
+1,432,301
| New | +$230M | 0.17% | 165 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Janus Henderson Group's ICUI Position: Q1 2026 in Review
Janus Henderson Group increased its ICU Medical (ICUI) stake by 3.9% in Q1 2026, buying an estimated $14.3M and bringing the position to 2,676,012 shares worth $346M. The position accounts for 0.17% of the portfolio, ranked #138.
Janus Henderson Group first reported a position in ICUI in Q2 2017 and has held it in 36 quarters since. The position peaked at $755M in Q3 2022. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Janus Henderson Group held 2,676,012 shares of ICU Medical worth $346M as of Q1 2026.
- Janus Henderson Group bought 99,256 ICU Medical shares in Q1 2026, an estimated $14.3M.
- ICU Medical made up 0.17% of Janus Henderson Group's portfolio in Q1 2026, its #138 holding.
- Janus Henderson Group first reported a position in ICU Medical in Q2 2017 and has held it in 36 quarters since.
- Janus Henderson Group's ICU Medical position peaked at $755M in Q3 2022.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.